Titre : Solutions

Solutions : Questions médicales fréquentes

Termes MeSH sélectionnés :

Interrupted Time Series Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Solutions : Questions médicales les plus fréquentes", "headline": "Solutions : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Solutions : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-29", "dateModified": "2025-02-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Solutions" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Préparations pharmaceutiques", "url": "https://questionsmedicales.fr/mesh/D004364", "about": { "@type": "MedicalCondition", "name": "Préparations pharmaceutiques", "code": { "@type": "MedicalCode", "code": "D004364", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Solution hypertonique", "alternateName": "Hypertonic Solutions", "url": "https://questionsmedicales.fr/mesh/D006982", "about": { "@type": "MedicalCondition", "name": "Solution hypertonique", "code": { "@type": "MedicalCode", "code": "D006982", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.314" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Solution hypertonique glucose", "alternateName": "Glucose Solution, Hypertonic", "url": "https://questionsmedicales.fr/mesh/D005950", "about": { "@type": "MedicalCondition", "name": "Solution hypertonique glucose", "code": { "@type": "MedicalCode", "code": "D005950", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.314.420" } } }, { "@type": "MedicalWebPage", "name": "Solution saline hypertonique", "alternateName": "Saline Solution, Hypertonic", "url": "https://questionsmedicales.fr/mesh/D012462", "about": { "@type": "MedicalCondition", "name": "Solution saline hypertonique", "code": { "@type": "MedicalCode", "code": "D012462", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.314.890" } } } ] }, { "@type": "MedicalWebPage", "name": "Solution hypotonique", "alternateName": "Hypotonic Solutions", "url": "https://questionsmedicales.fr/mesh/D007038", "about": { "@type": "MedicalCondition", "name": "Solution hypotonique", "code": { "@type": "MedicalCode", "code": "D007038", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.399" } } }, { "@type": "MedicalWebPage", "name": "Solution isotonique", "alternateName": "Isotonic Solutions", "url": "https://questionsmedicales.fr/mesh/D007552", "about": { "@type": "MedicalCondition", "name": "Solution isotonique", "code": { "@type": "MedicalCode", "code": "D007552", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.498" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cristalloïdes", "alternateName": "Crystalloid Solutions", "url": "https://questionsmedicales.fr/mesh/D000077324", "about": { "@type": "MedicalCondition", "name": "Cristalloïdes", "code": { "@type": "MedicalCode", "code": "D000077324", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.498.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Solution de Ringer au lactate", "alternateName": "Ringer's Lactate", "url": "https://questionsmedicales.fr/mesh/D000077325", "about": { "@type": "MedicalCondition", "name": "Solution de Ringer au lactate", "code": { "@type": "MedicalCode", "code": "D000077325", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.498.500.500" } } }, { "@type": "MedicalWebPage", "name": "Solution physiologique salée", "alternateName": "Saline Solution", "url": "https://questionsmedicales.fr/mesh/D000077330", "about": { "@type": "MedicalCondition", "name": "Solution physiologique salée", "code": { "@type": "MedicalCode", "code": "D000077330", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.498.500.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Solution de Ringer au lactate", "alternateName": "Ringer's Lactate", "url": "https://questionsmedicales.fr/mesh/D000077325", "about": { "@type": "MedicalCondition", "name": "Solution de Ringer au lactate", "code": { "@type": "MedicalCode", "code": "D000077325", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.498.500.500" } } }, { "@type": "MedicalWebPage", "name": "Solution physiologique salée", "alternateName": "Saline Solution", "url": "https://questionsmedicales.fr/mesh/D000077330", "about": { "@type": "MedicalCondition", "name": "Solution physiologique salée", "code": { "@type": "MedicalCode", "code": "D000077330", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.498.500.750" } } }, { "@type": "MedicalWebPage", "name": "Solution de Ringer", "alternateName": "Ringer's Solution", "url": "https://questionsmedicales.fr/mesh/D000077331", "about": { "@type": "MedicalCondition", "name": "Solution de Ringer", "code": { "@type": "MedicalCode", "code": "D000077331", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.498.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Solution conservation organe", "alternateName": "Organ Preservation Solutions", "url": "https://questionsmedicales.fr/mesh/D019188", "about": { "@type": "MedicalCondition", "name": "Solution conservation organe", "code": { "@type": "MedicalCode", "code": "D019188", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.675" } } }, { "@type": "MedicalWebPage", "name": "Solutions réhydratation", "alternateName": "Rehydration Solutions", "url": "https://questionsmedicales.fr/mesh/D015532", "about": { "@type": "MedicalCondition", "name": "Solutions réhydratation", "code": { "@type": "MedicalCode", "code": "D015532", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D26.776.741" } } } ], "about": { "@type": "MedicalCondition", "name": "Solutions", "alternateName": "Solutions", "code": { "@type": "MedicalCode", "code": "D012996", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xiao Wang", "url": "https://questionsmedicales.fr/author/Xiao%20Wang", "affiliation": { "@type": "Organization", "name": "Analytical Research and Development, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States." } }, { "@type": "Person", "name": "Xi Zhang", "url": "https://questionsmedicales.fr/author/Xi%20Zhang", "affiliation": { "@type": "Organization", "name": "Institute of Nanosurface Science and Engineering , Shenzhen University , Shenzhen 518060 , China." } }, { "@type": "Person", "name": "Sara Dovrat", "url": "https://questionsmedicales.fr/author/Sara%20Dovrat", "affiliation": { "@type": "Organization", "name": "Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel Hashomer, Israel." } }, { "@type": "Person", "name": "Ela Kashi-Zagdoun", "url": "https://questionsmedicales.fr/author/Ela%20Kashi-Zagdoun", "affiliation": { "@type": "Organization", "name": "Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel Hashomer, Israel." } }, { "@type": "Person", "name": "Zvia Soufiev", "url": "https://questionsmedicales.fr/author/Zvia%20Soufiev", "affiliation": { "@type": "Organization", "name": "Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel Hashomer, Israel." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Impact of COVID-19 pandemic on food availability and affordability: an interrupted time series analysis in Ghana.", "datePublished": "2024-05-08", "url": "https://questionsmedicales.fr/article/38720254", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-024-18745-x" } }, { "@type": "ScholarlyArticle", "name": "The effect of clinical guidelines on the utilisation of radiographs in chiropractic clinics in Denmark - an interrupted time series analysis.", "datePublished": "2023-11-22", "url": "https://questionsmedicales.fr/article/37993957", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12998-023-00518-9" } }, { "@type": "ScholarlyArticle", "name": "Impact of COVID-19 pandemic on Tuberculosis and HIV services in Ghana: An interrupted time series analysis.", "datePublished": "2023-09-20", "url": "https://questionsmedicales.fr/article/37729176", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0291808" } }, { "@type": "ScholarlyArticle", "name": "Using Preanesthesia Clinic Visits to Improve Advance Directives Completion: An Interrupted Time Series Analysis.", "datePublished": "2023-05-14", "url": "https://questionsmedicales.fr/article/37450641", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1213/ANE.0000000000006533" } }, { "@type": "ScholarlyArticle", "name": "Interrupted time series segmented regression analysis for detecting waterborne disease outbreaks by syndromic surveillance.", "datePublished": "2023-02-28", "url": "https://questionsmedicales.fr/article/36850065", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.33321/cdi.2023.47.5" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Préparations pharmaceutiques", "item": "https://questionsmedicales.fr/mesh/D004364" }, { "@type": "ListItem", "position": 3, "name": "Solutions", "item": "https://questionsmedicales.fr/mesh/D012996" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Solutions - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Solutions", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Solutions", "description": "Comment les solutions sont-elles utilisées en diagnostic ?\nQuelles solutions sont utilisées pour les tests sanguins ?\nQuel rôle des solutions dans l'imagerie médicale ?\nLes solutions peuvent-elles aider au diagnostic des infections ?\nComment les solutions sont-elles utilisées en microbiologie ?", "url": "https://questionsmedicales.fr/mesh/D012996?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Solutions", "description": "Quels symptômes peuvent nécessiter des solutions intraveineuses ?\nLes solutions peuvent-elles soulager des douleurs ?\nQuels symptômes indiquent une réaction à une solution ?\nComment les solutions affectent-elles l'hydratation ?\nQuels symptômes peuvent résulter d'une surhydratation ?", "url": "https://questionsmedicales.fr/mesh/D012996?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Solutions", "description": "Comment les solutions peuvent-elles prévenir les infections ?\nLes solutions de vaccination sont-elles efficaces ?\nQuel rôle des solutions dans la prévention de la déshydratation ?\nComment les solutions peuvent-elles prévenir les complications post-opératoires ?\nLes solutions peuvent-elles prévenir les allergies ?", "url": "https://questionsmedicales.fr/mesh/D012996?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Solutions", "description": "Quelles solutions sont utilisées pour traiter la déshydratation ?\nComment les solutions salines sont-elles utilisées en médecine ?\nLes solutions peuvent-elles être utilisées en chimiothérapie ?\nQuel est l'usage des solutions antiseptiques ?\nComment les solutions de glucose sont-elles utilisées ?", "url": "https://questionsmedicales.fr/mesh/D012996?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Solutions", "description": "Quelles complications peuvent survenir avec des solutions intraveineuses ?\nComment éviter les complications liées aux solutions ?\nLes solutions peuvent-elles causer des réactions allergiques ?\nQuelles complications peuvent résulter d'une surhydratation ?\nComment les solutions mal administrées peuvent-elles affecter la santé ?", "url": "https://questionsmedicales.fr/mesh/D012996?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Solutions", "description": "Quels facteurs augmentent le risque d'infections liées aux solutions ?\nLes allergies aux composants des solutions sont-elles courantes ?\nComment l'âge influence-t-il l'utilisation des solutions ?\nQuels médicaments peuvent interagir avec les solutions ?\nLes maladies chroniques augmentent-elles les risques liés aux solutions ?", "url": "https://questionsmedicales.fr/mesh/D012996?mesh_terms=Interrupted+Time+Series+Analysis&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment les solutions sont-elles utilisées en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elles servent à diluer des échantillons ou à administrer des agents de contraste." } }, { "@type": "Question", "name": "Quelles solutions sont utilisées pour les tests sanguins ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les solutions salines et les anticoagulants sont couramment utilisés." } }, { "@type": "Question", "name": "Quel rôle des solutions dans l'imagerie médicale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles améliorent la visibilité des structures internes lors des examens d'imagerie." } }, { "@type": "Question", "name": "Les solutions peuvent-elles aider au diagnostic des infections ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines solutions permettent d'identifier des agents pathogènes dans des échantillons." } }, { "@type": "Question", "name": "Comment les solutions sont-elles utilisées en microbiologie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elles servent à cultiver des micro-organismes pour les identifier." } }, { "@type": "Question", "name": "Quels symptômes peuvent nécessiter des solutions intraveineuses ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Déshydratation, déséquilibre électrolytique ou choc hypovolémique." } }, { "@type": "Question", "name": "Les solutions peuvent-elles soulager des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Certaines solutions anesthésiques peuvent être utilisées pour soulager la douleur." } }, { "@type": "Question", "name": "Quels symptômes indiquent une réaction à une solution ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, démangeaisons ou gonflement au site d'injection peuvent survenir." } }, { "@type": "Question", "name": "Comment les solutions affectent-elles l'hydratation ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à rétablir l'équilibre hydrique dans le corps." } }, { "@type": "Question", "name": "Quels symptômes peuvent résulter d'une surhydratation ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Œdème, hypertension et troubles respiratoires peuvent se manifester." } }, { "@type": "Question", "name": "Comment les solutions peuvent-elles prévenir les infections ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les solutions antiseptiques et désinfectantes réduisent le risque d'infection." } }, { "@type": "Question", "name": "Les solutions de vaccination sont-elles efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles contiennent des agents immunisants pour prévenir diverses maladies." } }, { "@type": "Question", "name": "Quel rôle des solutions dans la prévention de la déshydratation ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les solutions de réhydratation orale aident à maintenir l'hydratation, surtout chez les enfants." } }, { "@type": "Question", "name": "Comment les solutions peuvent-elles prévenir les complications post-opératoires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à maintenir l'équilibre hydrique et électrolytique après une chirurgie." } }, { "@type": "Question", "name": "Les solutions peuvent-elles prévenir les allergies ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines solutions peuvent être utilisées pour désensibiliser les patients allergiques." } }, { "@type": "Question", "name": "Quelles solutions sont utilisées pour traiter la déshydratation ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les solutions de réhydratation orale et intraveineuse sont couramment utilisées." } }, { "@type": "Question", "name": "Comment les solutions salines sont-elles utilisées en médecine ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour l'hydratation et comme diluants pour d'autres médicaments." } }, { "@type": "Question", "name": "Les solutions peuvent-elles être utilisées en chimiothérapie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles servent à administrer des agents chimiothérapeutiques par voie intraveineuse." } }, { "@type": "Question", "name": "Quel est l'usage des solutions antiseptiques ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour désinfecter les plaies et prévenir les infections." } }, { "@type": "Question", "name": "Comment les solutions de glucose sont-elles utilisées ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles fournissent une source rapide d'énergie et sont utilisées en cas d'hypoglycémie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des solutions intraveineuses ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Infections, phlébite ou surhydratation peuvent se produire." } }, { "@type": "Question", "name": "Comment éviter les complications liées aux solutions ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une administration correcte et une surveillance régulière sont essentielles." } }, { "@type": "Question", "name": "Les solutions peuvent-elles causer des réactions allergiques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines solutions peuvent provoquer des réactions allergiques chez certains patients." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter d'une surhydratation ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Œdème pulmonaire et hypertension intracrânienne peuvent survenir." } }, { "@type": "Question", "name": "Comment les solutions mal administrées peuvent-elles affecter la santé ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des déséquilibres électrolytiques et des complications graves." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'infections liées aux solutions ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise hygiène et des techniques d'administration inappropriées augmentent le risque." } }, { "@type": "Question", "name": "Les allergies aux composants des solutions sont-elles courantes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent être allergiques à des agents présents dans les solutions." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il l'utilisation des solutions ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les jeunes enfants et les personnes âgées sont plus sensibles aux effets des solutions." } }, { "@type": "Question", "name": "Quels médicaments peuvent interagir avec les solutions ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent provoquer des interactions indésirables avec des solutions." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles les risques liés aux solutions ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients atteints de maladies chroniques peuvent avoir des risques accrus." } } ] } ] }

Sources (10000 au total)

Impact of COVID-19 pandemic on food availability and affordability: an interrupted time series analysis in Ghana.

In Africa, approx. 675 million people were at risk of food insecurity. COVID-19 pandemic is likely to have exacerbated this situation, by damaging populations' access to and affordability of foods. Th... Data on food availability and food retail prices collected through weekly market-level data during the period from July 2017 to September 2020 were used in this study. We performed interrupted time-se... As a result, the impact of COVID-19 on food availability was limited. However, the results of interrupted time-series analyses indicate a significant increase in overall mean food prices in Greater Ac... The impact of COVID-19 pandemic on food availability and prices was significant but varied by food type and regions in Ghana. Continuous monitoring and responses are critical to maintain food availabi...

The effect of clinical guidelines on the utilisation of radiographs in chiropractic clinics in Denmark - an interrupted time series analysis.

In Denmark, chiropractors have a statutory right to use radiography and the government-funded national Health Insurance provides partial reimbursement. Danish National Clinical Guidelines recommends a... Anonymised data from January 1st, 2010, to December 31st, 2020, were extracted from the Danish Regions register on health contacts in primary care. Data consisted of the total number of patients consu... In total, 336,128 unique patients consulted a chiropractor in 2010 of which 55,449 (15.4%) had radiography. In 2020, the number of patients consulting a chiropractor had increased to 366,732 of which ... The proportion of Danish chiropractic patients undergoing radiography was halved in the period from 2010 to 2020. However, the dissemination of clinical imaging guidelines recommendations and policy c...

Impact of COVID-19 pandemic on Tuberculosis and HIV services in Ghana: An interrupted time series analysis.

The Coronavirus disease 2019 (COVID-19) burden, coupled with unprecedented control measures including physical distancing, travel bans, and lockdowns of cities, implemented to stop the spread of the v... The study involved the analysis of secondary data obtained from the District Health Information Management System-2 (DHIMS-2) database of Ghana Health Service, from 2016 to 2020. Data were analysed us... The study showed that during the COVID-19 pandemic period, there was an abrupt decline of 20.5% (955CI: 16.0%, 24.5%) in TB case notifications in April and 32.7% (95%CI: 28.8%, 39.1%) in May 2020, wit... This study demonstrated that the COVID-19 pandemic negatively impacted TB case notifications and HIV testing and counselling services, However, ART initiation was generally not impacted during the fir...

Using Preanesthesia Clinic Visits to Improve Advance Directives Completion: An Interrupted Time Series Analysis.

Advance directives documentation can increase the likelihood that patient's wishes are respected if they become incapacitated. Unfortunately, completion rates are suboptimal overall, and disparities m... We conducted a before-after interrupted time series evaluation between January 1, 2015 and June 30, 2019 in a single-center, outpatient preanesthesia clinic. Participants were adults who visited the p... We included 26,368 visits from 22,430 patients. We analyzed financial status for 16,788 visits from 14,274 patients who had address data. There were 11,242 (43%) visits preintervention and 15,126 (57%... Standardizing advance directives discussions during preanesthesia visits was associated with more patients completing advance directives, particularly in vulnerable patient groups....

Interrupted time series segmented regression analysis for detecting waterborne disease outbreaks by syndromic surveillance.

Pathogens can enter the drinking water supply and cause gastroenteritis outbreaks. Such events can affect many people in a short time, making them a high risk for public health. In Australia, the Vict... The study involved an interrupted time series study of a past lapse in water treatment. The baseline period comprised the four weeks before the minimum incubation period of suspected pathogens, set at... In the retrospective analysis, there was strong evidence for an increase in presentations shortly after the event. In the simulations, with no excess presentations (i.e., with the ED data as is) the m... The transient increase in presentations after the event may be attributed to microbiological hazards or increased health-seeking behaviour following the issuing of boil water advisories. The simulatio...

Impact of alcohol taxes on violence in Hong Kong: a population-based interrupted time series analysis.

Interpersonal violence is a major public health concern with alcohol use a known risk factor. Despite alcohol taxation being an effective policy to reduce consumption; Hong Kong, contrary to most deve... To assess the impact of the alcohol tax reductions, we analysed population-based hospitalisation data for assault from the Hong Kong Hospital Authority, and violent and sexual crimes recorded by the H... The 2007 tax cut was associated with sustained increases in violence-related hospitalisation rates for 35-49 age group (female: 0.19%, p=0.007; male: 0.22%, p<0.001; overall: 0.16%, p=0.007); and an i... Both alcohol tax reductions in 2007 and 2008 were in some age groups associated with increases in violence-related hospitalisations and reports of sexual assault even in an environment of low crime....

Impact of COVID-19 pandemic on road traffic injuries in Iran: An interrupted time-series analysis.

Globally, the COVID-19 pandemic has affected the number of road accidents and deaths caused by them. The present study aimed to identify the effect of this epidemic on traffic accidents and their casu... In this study, Interrupted Time Series Analysis (ITSA) was used in a semi-experimental design to measure the impact of the restrictive policies of COVID-19 on road accidents. Data were collected retro... Since February 2020 in Iran, the reduction in the number of road accidents and the number of injuries and deaths in these accidents was significant at 5% but the reduction of deaths in the scene and h... In the early months of the COVID-19 epidemic in Iran, the number of road accidents and their casualties decreased. Policies restricting traffic, quarantine, and fines for violators can be reasons for ...

Pediatric Injury Transfer Patterns During the COVID-19 Pandemic: An Interrupted time Series Analysis.

With the expected surge of adult patients with COVID-19, the Children's Hospital Association recommended a tiered approach to divert children to pediatric centers. Our objective was understanding chan... Children aged < 18 y injured between January 1, 2016 and September 30, 2020, who met National Trauma Databank inclusion criteria from 9 PTCs were included. An interrupted time-series analysis was used... Twenty seven thousand thirty one/47,382 injured patients (57.05%) were transferred to a participating PTC during the study period. Of the COVID cohort, 65.4% (4620/7067) were transferred, compared to ... Transferred trauma patients to Level I PTC increased during the COVID-19 pandemic. The proportion of transferred patients discharged from emergency departments increased. Pediatric trauma transfers ma...

The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis.

The Belgian government has taken several measures to increase the uptake of biosimilars in past years. However, no formal evaluation of the impact of these measures has been made yet. This study aimed... An interrupted time series analysis was performed using an autoregressive integrated moving average (ARIMA) model with the Box-Jenkins method. All data were expressed as defined daily doses (DDD) per ... In the ambulatory care, the effect of a financial prescriber incentive of 2019 was investigated. After this intervention, 44.504 (95% CI -61.61 to -14.812; P < 0.001) fewer etanercept biosimilar DDDs ... The results of this study suggest that the impact of past policy interventions to increase the uptake of biosimilars has been variable and limited. A holistic policy framework is required to develop a...

Prophylactic Enoxaparin Against Catheter-Associated Thrombosis in Postoperative Cardiac Children: An Interrupted Time Series Analysis.

The effectiveness of pharmacologic prophylaxis against catheter-associated thrombosis in children is unclear. We evaluated the compliance and outcomes associated with a prophylactic enoxaparin protoco... The protocol was implemented as a quality improvement initiative and then analyzed using interrupted time series method. Data collected from November 2014 to December 2018 were divided into preprotoco... A 12-bed academic pediatric cardiac ICU.... Children less than or equal to 18 years old with congenital heart disease admitted postoperatively with central venous catheter in situ for greater than or equal to 1 day.... Before 2016, prophylactic enoxaparin was administered according to physician preference. In January 2016, an enoxaparin protocol was implemented with a goal anti-Xa range of 0.25-0.49 international un... We analyzed 780 hospitalizations from 636 children. Median percentage of catheter-days on prophylactic enoxaparin was 33% (interquartile range [IQR], 23-47%), 42% (IQR, 30-51%), and 38% (IQR, 35-52%) ... The temporal association between increase in percentage of catheter-days on enoxaparin and decrease in rate of thrombosis suggests the effectiveness of prophylactic enoxaparin....